Literature DB >> 15709156

Transmission and prenatal diagnosis of the T9176C mitochondrial DNA mutation.

L J A M Jacobs1, I F M de Coo, J G Nijland, R J H Galjaard, F J Los, K Schoonderwoerd, M F Niermeijer, J P M Geraedts, H R Scholte, H J M Smeets.   

Abstract

A family presented with three affected children with Leigh syndrome, a progressive neurodegenerative disorder. Analysis of the OXPHOS complexes in muscle of two affected patients showed an increase in activity of pyruvate dehydrogenase and a decrease of complex V activity. Mutation analysis revealed the T9176C mutation in the mtATPase 6 gene (OMIM 516060) and the mutation load was above 90% in the patients. Unaffected maternal relatives were tested for carrier-ship and one of them, with a mutation load of 55% in blood, was pregnant with her first child. The possibility of prenatal diagnosis was evaluated. The main problem was the lack of data on genotype-phenotype associations for the T9176C mutation and on variation of the mutation percentage in tissues and in time. Therefore, multiple tissues of affected and unaffected carriers were analysed. Eventually, prenatal diagnosis was offered with understanding by the couple that there could be considerable uncertainty in the interpretation of the results. Prenatal diagnosis was carried out twice on cultured and uncultured chorion villi and amniotic fluid cells. The result was a mutation percentage just below the assumed threshold of expression (90%). The couple decided to continue the pregnancy and an apparently healthy child was born with an as yet unclear prognosis. This is the first prenatal diagnosis for a carrier of the T9176C mutation. Prenatal diagnosis for this mutation is technically reliable, but the prognostic predictions are not straightforward.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15709156     DOI: 10.1093/molehr/gah152

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  12 in total

Review 1.  Stem cell-based models and therapies for neurodegenerative diseases.

Authors:  Shilpa Iyer; Khaled Alsayegh; Sheena Abraham; Raj R Rao
Journal:  Crit Rev Biomed Eng       Date:  2009

Review 2.  Mitochondrial DNA mutations in human disease.

Authors:  Robert W Taylor; Doug M Turnbull
Journal:  Nat Rev Genet       Date:  2005-05       Impact factor: 53.242

Review 3.  MT-ATP6 mitochondrial disease variants: Phenotypic and biochemical features analysis in 218 published cases and cohort of 14 new cases.

Authors:  Rebecca D Ganetzky; Claudia Stendel; Elizabeth M McCormick; Zarazuela Zolkipli-Cunningham; Amy C Goldstein; Thomas Klopstock; Marni J Falk
Journal:  Hum Mutat       Date:  2019-03-04       Impact factor: 4.878

4.  Consequences of the pathogenic T9176C mutation of human mitochondrial DNA on yeast mitochondrial ATP synthase.

Authors:  Roza Kucharczyk; Nahia Ezkurdia; Elodie Couplan; Vincent Procaccio; Sharon H Ackerman; Marc Blondel; Jean-Paul di Rago
Journal:  Biochim Biophys Acta       Date:  2010-01-04

5.  Preimplantation genetic diagnosis for mitochondrial DNA disorders: ethical guidance for clinical practice.

Authors:  Annelien Bredenoord; Wybo Dondorp; Guido Pennings; Christine de Die-Smulders; Bert Smeets; Guido de Wert
Journal:  Eur J Hum Genet       Date:  2009-05-27       Impact factor: 4.246

6.  Preventing the transmission of pathogenic mitochondrial DNA mutations: Can we achieve long-term benefits from germ-line gene transfer?

Authors:  David C Samuels; Passorn Wonnapinij; Patrick F Chinnery
Journal:  Hum Reprod       Date:  2013-01-07       Impact factor: 6.918

7.  Response to immunotherapy in a patient with adult onset Leigh syndrome and T9176C mtDNA mutation.

Authors:  Miguel Chuquilin; Raghav Govindarajan; Dawn Peck; Esperanza Font-Montgomery
Journal:  Mol Genet Metab Rep       Date:  2016-07-01

8.  Response to letter to the editor: Why does Leigh syndrome responds to immunotherapy?

Authors:  Miguel Chuquilin; Raghav Govindarajan; Dawn Peck; Esperanza Font Montgomery
Journal:  Mol Genet Metab Rep       Date:  2016-08-09

9.  De novo mtDNA point mutations are common and have a low recurrence risk.

Authors:  Suzanne C E H Sallevelt; Christine E M de Die-Smulders; Alexandra T M Hendrickx; Debby M E I Hellebrekers; Irenaeus F M de Coo; Charlotte L Alston; Charlotte Knowles; Robert W Taylor; Robert McFarland; Hubert J M Smeets
Journal:  J Med Genet       Date:  2016-07-22       Impact factor: 6.318

10.  A national perspective on prenatal testing for mitochondrial disease.

Authors:  Victoria Nesbitt; Charlotte L Alston; Emma L Blakely; Carl Fratter; Catherine L Feeney; Joanna Poulton; Garry K Brown; Doug M Turnbull; Robert W Taylor; Robert McFarland
Journal:  Eur J Hum Genet       Date:  2014-03-19       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.